<DOC>
	<DOCNO>NCT00494572</DOCNO>
	<brief_summary>The purpose study determine montelukast , addition standard treatment helpful treat patient age 6-18 hospital status asthmaticus .</brief_summary>
	<brief_title>Montelukast With Status Asthmaticus , Ages 6-18</brief_title>
	<detailed_description>This prospective study montelukast efficacy addition standard treatment status asthmaticus child PICU . The study stratify 2 group : child 6-12 year age adolescents 13-18 year age . Children meet eligibility requirement randomize receive rapid-dissolving oral dose montelukast placebo . Participants give physical exam , FEV1 measurements clinical asthma score record pre- post- completion nebulized albuterol treatment 0.1 mg/kg/dose ( min 2.5 mg/dose ) . Blood sample PK analysis collect prior study drug administration predetermine time interval determine plasma level montelukast . In addition , blood sample obtain genetic study polymorphism CYP3A4 , CYP3A5 , CYP2C9 .</detailed_description>
	<mesh_term>Status Asthmaticus</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>Participant 's parent/legal guardian must give write informed consent write assent must obtain form subject prior study participation . 1 . Obtain consent parent/legal guardian use signed consent form ; 2 . Obtain assent form minor age 713 use sign assent form ; 3 . Obtain assent minor age 1417 subject sign consent form signed parent / legal guardian ( Or base assessment Primary Investigator patient unable comprehend study write consent form document , patient may document assent sign assent form ) . Participant , male female , must 6 18 year age . Participant must history reactive airway disease ( RAD ) asthma must currently admit acute exacerbation RAD asthma . Primary physician must believe patient would benefit improved bronchodilation improvement clinical asthma severity score . Participant must receive standard therapy status asthmaticus : 1 . Oxygen need 2 . &gt; 3 nebulized albuterol treatment least 2.5mg/dose 3 . Methylprednisolone prednisone load dose 2mg/kg 4 . Ongoing methylprednisolone therapy @ 0.5mg/kg every 6 hour Participant must receive steroid least 6 hour prior inclusion , must still require nebulized albuterol least every 2 hour , determine PICU team accordance PICU standard evaluate treat patient RAD asthma exacerbation . Participant must indwell catheter place obtain blood specimen . Catheter may peripheral central , arterial venous . Known hypersensitivity montelukast Chronic lung disease RAD asthma Known renal disease Known hepatic disease Cardiac pulmonary congenital anomaly Known immunologic disorder allergy atopy Other explanation respiratory distress Use leukotriene modifier within 2 week acute presentation Pregnant female Intubated patient Inability participate portable spirometry FEV1 measurement</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>November 2008</verification_date>
	<keyword>Montelukast</keyword>
	<keyword>Albuterol</keyword>
	<keyword>Status Asthmaticus</keyword>
	<keyword>Asthma</keyword>
</DOC>